Search Results 1771-1780 of 11552 for total t4
The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS) ...
The purpose of this study is to evaluate the effectiveness of cilta-cel OOS based on overall response of partial response (PR) or better (overall response rate, ...
A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.
Mayo Clinic researchers will join collaborators on a federally-funded project to improve the treatment of patients with type 2 diabetes and obesity. Latest ...
Participation eligibility · Age greater than or equal to 15 years. · Neurological disease or disorder diagnosis. · Internet access and/or ability to complete paper ...
The purpose of this study is to compare overall survival between surgical septal myectomy and alcohol septal ablation. The study will also compare ...
Subject has had extensive colonic resection (i.e., more than half of colon), subtotal or total colectomy, intestinal resection within 6 months of Screening ...
Total bilirubin >1.7 times the ULN (except in case of Gilbert's syndrome) (1 repeat lab allowed);; Amylase and/or lipase >3 times the ULN (1 repeat lab ...
Total bilirubin >1.5x ULN (unless due to Gilbert's Syndrome). Has received other anti-cancer therapy within the following specified intervals prior to Day 1 ...
NOTE: Criteria 1 and 2 above mean that patients who enrolled in CAMMS323 or CAMMS324 but did not complete the 2-year study period or went on to receive non ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!